Project 1: Dynamic Interplay of Eicosanoids in Cardiovascular Biology Products of the cyclooxygenase (C0X)-2 have been directly implicated in both inflammatory and thrombotic disease. However, predominant products of the COX enzymes vary between cells and have contrasting biology. The microsomal PGE synthase (mPGES)-1 has emerged as a drug target alternative to COX-2. A combined genetic and pharmacological approach will be taken to elucidate the roles of these enzymes in discrete cells and to assess the impact of COX-2 perturbation on biological networks. Versatile biomarkers of inflammation and oxidant stress will be combined in lipidomic analyses to integrate the divergent impact of cell specific enzyme disruptions on atherosclerosis in vivo with mechanistic studies in vitro.
In Specific Aim 1 we shall assess the importance of COX-2 in endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) in regulating (i) the response to thrombogenic stimuli in large and small blood vessels and (ii) blood pressure homeostasis. Analysis of these phenotypes in mice deficient in discrete prostanoid receptors and cell specific deletions of COX-2 will be compared with the effects of global disruption of COX -2 function using genetic and pharmacological approaches.
In Specific Aim 2 we shall seek to elucidate the controversy surrounding COX-2 inhibition and atherosclerosis. The impact of induced global deletion of the enzyme will be assessed at varied stages of disease evolution, as will the distinct roles of EC, VSMC and macrophage COX-2 on prostanoid biosynthesis, the inflammatory response and lesional progression and morphology. Multiple tissues will be harvested from these and other mice with discrete deletions of COX-2 to determine how enzyme perturbation might impact on biological networks relevant to inflammation and how this might be influenced by age, gender and diet.
In Specific Aim 3 we will utilize both a novel selective inhibitor of mPGES-1 and cell specific deletions ofthe enzyme to address the hypothesis that contrasting, functionally relevant patterns of substrate rediversion might ocpur at different stages of disease evolution. Unbiased analyses will be performed of the comparative impact of mPGES-1 vs COX-2 deletion on the response to inflammatory stimuli in discrete cell types. Finally, in Specific Aim 4, we shall assess the effect of deleting COX-2 or mPGES-1 in discrete cells - that differ in their primary prostanoids or rediversion products - on the response to vascular injury. We shall also determine whether systemic hypertension might exacerbate the impact of deleting either enzyme in cardiomyocytes on heart function and rhythm.

Public Health Relevance

These studies will elucidate the cardiovascular biology of both COX-2 and mPGES-1 with particular relevance to atherosclerosis. This is relevant to development of strategies to manage scientifically the cardiovascular risk while conserving the benefit of NSAIDs and in the prediction of the relative cardiovascular safety of inhibitors of mPGES-1.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
United States
Zip Code
Paschos, Georgios K; Tang, Soon Yew; Theken, Katherine N et al. (2018) Cold-Induced Browning of Inguinal White Adipose Tissue Is Independent of Adipose Tissue Cyclooxygenase-2. Cell Rep 24:809-814
Davies, Peter F; Manduchi, Elisabetta; Jiménez, Juan M et al. (2017) Biofluids, cell mechanics and epigenetics: Flow-induced epigenetic mechanisms of endothelial gene expression. J Biomech 50:3-10
Davies, Peter F; Manduchi, Elisabetta; Stoeckert, Christian J et al. (2016) SY 15-2 ENDOTHELIAL EPIGENETICS AND ITS ROLE IN MEDIATING BIOMECHANICAL STRESS OF HYPERTENSION. J Hypertens 34 Suppl 1 - IS:e371
Bae, Yong Ho; Liu, Shu-Lin; Byfield, Fitzroy J et al. (2016) Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy. J Vis Exp :
Tang, Soon Yew; Monslow, James; R Grant, Gregory et al. (2016) Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1-Deficient Hyperlipidemic Mice. Circulation 134:328-38
Hsu, Bernadette Y; Bae, Yong Ho; Mui, Keeley L et al. (2015) Apolipoprotein E3 Inhibits Rho to Regulate the Mechanosensitive Expression of Cox2. PLoS One 10:e0128974
Han, Jingyan; Shuvaev, Vladimir V; Davies, Peter F et al. (2015) Flow shear stress differentially regulates endothelial uptake of nanocarriers targeted to distinct epitopes of PECAM-1. J Control Release 210:39-47
Jiang, Yi-Zhou; Manduchi, Elisabetta; Jiménez, Juan M et al. (2015) Endothelial epigenetics in biomechanical stress: disturbed flow-mediated epigenomic plasticity in vivo and in vitro. Arterioscler Thromb Vasc Biol 35:1317-26
Liu, Shu-Lin; Bae, Yong Ho; Yu, Christopher et al. (2015) Matrix metalloproteinase-12 is an essential mediator of acute and chronic arterial stiffening. Sci Rep 5:17189
Sweet, Daniel T; Jiménez, Juan M; Chang, Jeremy et al. (2015) Lymph flow regulates collecting lymphatic vessel maturation in vivo. J Clin Invest 125:2995-3007

Showing the most recent 10 out of 163 publications